September 10, 2025Cancer DiscoveryOpen Access

Decoding the Genomic and Functional Landscape of Emerging Subtypes in Ovarian Cancer

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Analysis reveals distinct ovarian cancer subtypes, indicating potential targeted therapies for HRP patients.

Five ovarian cancer subtypes were identified, influencing treatment responses and therapeutic strategies.
Seventy percent of tumors harbored distinct genomic features, impacting responses to PARP inhibitors and platinum-based chemotherapy.
Organoid experiments indicated subtype-specific sensitivity to CHK1 inhibition, highlighting novel treatment avenues.
This research enhances understanding of tumor heterogeneity in ovarian cancer, offering potential individualized therapies.

Micoli et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark